Independent physician consulting for VA disability attorneys & law firmsClare, Michigan · Nationwide record review
Home / Attorney Resources / Camp Lejeune Water Contamination: What the Evidence Shows—and What the Presumption Does Not
Attorney resource · toxic exposure

Camp Lejeune Water Contamination: What the Evidence Shows—and What the Presumption Does Not

A physician review of the current Camp Lejeune evidence base, VA presumptive conditions, and the medical analysis that remains necessary in non-presumptive or otherwise complex cases.

The bottom line

Camp Lejeune has strong exposure evidence and defined VA presumptions—but the difficult cases still require individualized analysis.

VA currently presumes service connection for eight specified conditions in qualifying Camp Lejeune or MCAS New River service. For diagnoses outside that list, the medical question becomes more demanding: what does the exposure literature actually show, how well does it fit the Veteran’s disease, and what competing causes must be weighed?

A large exposed military cohort now provides stronger cancer-incidence data

ATSDR’s 2024 cancer-incidence study compared 154,821 Marines, Navy personnel, and civilian workers stationed at or employed at Camp Lejeune with 163,484 comparison personnel and workers associated with Camp Pendleton. ATSDR describes it as one of the largest studies of its type in the United States and reports increased risk of several cancers among exposed groups.

154,821 exposed cohortCamp Lejeune Marines, Navy personnel, and civilian workers in the cancer-incidence study.
163,484 comparison cohortCamp Pendleton personnel and workers used as a comparison population without known similar drinking-water contamination before 1986.

Among Marines and Navy personnel, ATSDR reports increased risk for some leukemias and lymphomas and for cancers of the lung, breast, larynx, esophagus, thyroid, and soft tissue. The peer-reviewed study was published in Environmental Health Perspectives.

What VA currently presumes

For qualifying service of at least 30 cumulative days at Camp Lejeune or MCAS New River between August 1, 1953 and December 31, 1987, VA lists eight presumptive disability conditions.

  • Adult leukemia
  • Aplastic anemia and other myelodysplastic syndromes
  • Bladder cancer
  • Kidney cancer
  • Liver cancer
  • Multiple myeloma
  • Non-Hodgkin lymphoma
  • Parkinson’s disease

When the service and diagnosis satisfy the presumption, the medical nexus question may already be resolved by the VA framework. That does not necessarily resolve the severity of the disease, residuals, secondary complications, employability, or a separate diagnosis outside the presumptive list.

Important distinction: VA’s list of conditions eligible for no-copay health care related to Camp Lejeune is broader than the eight-condition disability-compensation presumption. Those two lists should not be treated as medically or legally interchangeable.

Where individualized medical analysis becomes important

Non-presumptive cases require more than showing that the Veteran lived or worked at Camp Lejeune and later developed disease. A useful opinion should identify the relevant contaminant evidence, the disease-specific epidemiology, the Veteran’s period and circumstances of exposure, expected latency, disease phenotype, and major alternative causes.

QuestionPhysician focus
Presumptive diagnosisConfirm the medical diagnosis and address severity, residuals, secondary effects, or functional impairment if those are the issues counsel needs analyzed.
Non-presumptive cancer or diseaseAssess contaminant-specific and disease-specific evidence rather than relying on the fact of Camp Lejeune service alone.
Competing risk factorsAddress smoking history, age, family history, occupational exposures, metabolic risk, other carcinogens, and relevant post-service history.
Negative C&P opinionDetermine whether the examiner accurately characterized the current Camp Lejeune literature, distinguished legal presumptions from medical evidence, and weighed the Veteran’s individual facts.

What the 2024 study adds—and what it does not

The 2024 ATSDR cancer-incidence study is important because it evaluates actual cancer incidence in a very large military and civilian cohort rather than relying only on mortality. Its findings can materially inform medical plausibility for some diseases and may be relevant when counsel is evaluating a diagnosis outside the current presumptive list.

But an elevated population risk does not establish individual causation. The study does not tell a physician that a particular Veteran’s cancer was caused by Camp Lejeune water exposure. The individual opinion still requires a reasoned bridge from the population evidence to the Veteran’s exposure history, medical chronology, disease characteristics, and competing causes.

The physician’s role in a difficult Camp Lejeune case

A strong review should start by separating what is conceded or presumed from what remains disputed. If exposure is established, the physician should avoid spending pages proving the obvious and instead focus on the unresolved medical issue. If the condition is non-presumptive, the analysis should be explicit about the strength and limitations of the available literature and should not imply a level of certainty the evidence does not support.

This resource concerns VA disability medical analysis. Camp Lejeune Justice Act litigation is a separate legal pathway with its own standards and procedural issues; those questions should be defined by counsel before a medical causation assignment is accepted.

Scope: This page discusses medical evidence relevant to VA disability review. It does not provide legal advice, determine eligibility, or establish causation in an individual case.

Discuss a potential assignment with Dr. Townsend.

Valor works through counsel. The public inquiry is for introductions and case discussions; formal evaluation requests and records are exchanged directly after contact.

Law Firm Inquiry